| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 76 | 92 | 103 | 109 | 92 | 77 | 47 | 47 | 55 | 62 | 67 | 84 | 76 | 95 | 91 | 102 | 83 | 81 | 89 | 69 | 75 | 70 | 73 | 92 | 93 | 81 | 85 | 92 | 84 |
| Expenses | 71 | 82 | 91 | 100 | 82 | 68 | 44 | 42 | 48 | 54 | 60 | 74 | 68 | 77 | 83 | 89 | 74 | 73 | 79 | 62 | 72 | 61 | 63 | 79 | 76 | 70 | 72 | 82 | 71 |
| EBITDA | 5 | 10 | 13 | 9 | 10 | 9 | 3 | 5 | 7 | 8 | 7 | 10 | 8 | 18 | 9 | 13 | 9 | 8 | 10 | 7 | 3 | 8 | 10 | 14 | 17 | 11 | 13 | 10 | 13 |
| Operating Profit % | 6 % | 11 % | 12 % | 7 % | 11 % | 11 % | 6 % | 8 % | 12 % | 13 % | 10 % | 10 % | 11 % | 11 % | 9 % | 7 % | 10 % | 10 % | 11 % | 4 % | 3 % | 11 % | 13 % | 13 % | 18 % | 11 % | 15 % | 8 % | 14 % |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
| Profit Before Tax | 4 | 7 | 9 | 6 | 7 | 6 | -0 | 1 | 4 | 5 | 4 | 7 | 5 | 14 | 4 | 9 | 5 | 4 | 6 | 2 | -3 | 2 | 4 | 7 | 11 | 5 | 7 | 4 | 7 |
| Tax | 1 | 2 | 3 | 1 | 2 | 2 | 0 | -0 | 1 | 2 | 2 | 2 | 1 | 3 | 2 | 1 | 2 | 1 | 2 | 0 | 1 | 2 | -0 | 1 | 4 | 1 | 2 | 1 | 3 |
| Net Profit | 3 | 5 | 6 | 5 | 5 | 4 | -0 | 2 | 3 | 3 | 3 | 5 | 4 | 10 | 2 | 8 | 2 | 3 | 4 | 2 | -4 | -0 | 4 | 7 | 7 | 3 | 5 | 4 | 4 |
| EPS in ₹ | 9.51 | 15.60 | 18.77 | 15.22 | 15.61 | 12.18 | -1.12 | 5.20 | 8.21 | 10.96 | 8.92 | 16.72 | 12.00 | 33.91 | 7.70 | 26.00 | 9.95 | 9.10 | 13.18 | 5.66 | -5.94 | 2.20 | 14.24 | 19.53 | 23.15 | 15.46 | 18.08 | 9.83 | 13.75 |
SMS Lifesciences
SMS Lifesciences
1,149.20
-56.10
(-4.65%)
Market Cap
347.40 Cr
EPS
66.51
PE Ratio
20.05
Dividend Yield
0.13 %
Industry
Healthcare52 Week High
1,690.00
52 Week Low
959.80
PB Ratio
1.76
Debt to Equity
0.58
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Haleos Labs Limited Completes Brazilian Health Authority Audit of API Manufacturing Facility
1 day ago
1 day agoHaleos Labs Limited announced that its API manufacturing facility in Telangana has successfully completed an inspection by the Brazilian Health Authority (ANVISA) conducted from September 22-26, 2025. The company stated this inspection reaffirms compliance with international quality standards and creates opportunities for entry into Brazil, described as the largest pharmaceutical market in South America. The company was formerly known as SMS Lifesciences India Limited and is currently in the process of adopting the new name in compliance with regulatory requirements.
SMS Lifesciences India Limited has fixed September 24, 2025 as the record date for determining shareholder eligibility for dividend payments for 2024-25 and voting rights at the 19th Annual General Meeting scheduled for September 30, 2025 at 3:00 pm. The dividend, if approved by shareholders, will be paid within 30 days subject to tax deduction at source through direct bank account credits. The company has launched the 'Saksham Niveshak' 100-day campaign running from July 28 to November 6, 2025, aimed at reducing unclaimed dividends by facilitating KYC updates, bank mandate registrations, and claims for unpaid dividends from 2018-19 to 2023-24. The initiative seeks to prevent transfer of shares and dividends to the Investor Education and Protection Fund Authority by encouraging shareholders to update records and claim entitlements directly from the company.
SMS Lifesciences India Limited's Board of Directors approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported revenue from operations of Rs 7,904.27 lakhs compared to Rs 8,657.06 lakhs in the same quarter last year. Net profit decreased to Rs 515.77 lakhs from Rs 645.99 lakhs year-over-year. Earnings per share stood at Rs 17.06 versus Rs 21.37 in the previous year quarter. On a consolidated basis, revenue from operations was Rs 8,250.46 lakhs against Rs 9,254.82 lakhs in the corresponding quarter of the previous year. The company scheduled its 19th Annual General Meeting for September 30, 2025, to be conducted through video conferencing. The Board also approved various policies including Code of Conduct for Prevention of Insider Trading and Policy on determination of material events information.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,586.70 | #1 3,80,702.50 | 33.18 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 51.86 | |
5,689.50 | 1,51,038.30 | 65.50 | 9,712.00 | 18.67 | 2,191 | 26.74 | 36.39 | |
1,499.40 | 1,21,107.70 | 22.45 | 28,409.50 | 7.12 | 5,291 | 9.88 | 38.89 | |
3,561.00 | 1,20,520.40 | 59.72 | 11,539.40 | 6.99 | 1,911 | 19.91 | 42.61 | |
1,253.10 | 1,04,580.10 | #1 18.40 | 33,741.20 | 16.73 | 5,725 | 1.26 | 46.51 | |
2,482.90 | 1,02,476.40 | 54.18 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 44.66 | |
975.00 | 98,107.80 | 21.07 | 23,511.00 | 18.55 | 4,615 | 2.60 | 50.50 | |
1,919.80 | 87,676.40 | 23.72 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.16 | |
5,433.00 | 64,959.70 | 28.53 | 13,458.30 | 3.70 | 2,216 | 21.39 | 61.31 | |
1,090.00 | 63,307.40 | 18.84 | 32,345.60 | 9.43 | 3,484 | -10.24 | 53.78 |
Forecast
Actual
Growth Rate
Revenue Growth
-2.76 %
Net Income Growth
-44.74 %
Cash Flow Change
65.37 %
ROE
-45.86 %
ROCE
-9.16 %
EBITDA Margin (Avg.)
12.91 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 270 | 253 | 302 | 357 | 395 | 391 | 390 |
| Fixed Assets | 119 | 124 | 130 | 142 | 228 | 223 | 232 |
| Current Assets | 142 | 107 | 126 | 156 | 159 | 155 | 151 |
| Capital Work in Progress | 3 | 16 | 38 | 51 | 1 | 6 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 67 |
| Other Assets | 148 | 113 | 134 | 164 | 166 | 161 | 0 |
| Total Liabilities | 270 | 253 | 302 | 357 | 395 | 391 | 390 |
| Current Liabilities | 125 | 87 | 114 | 135 | 134 | 145 | 142 |
| Non Current Liabilities | 39 | 50 | 59 | 56 | 73 | 52 | 36 |
| Total Equity | 106 | 116 | 129 | 165 | 188 | 194 | 197 |
| Reserve & Surplus | 103 | 113 | 126 | 149 | 166 | 174 | 194 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Cash Flow
| Cash Flow | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 1 | 0 | 6 | -8 | 0 | -1 |
| Investing Activities | -44 | -27 | -26 | -7 | -31 | -19 |
| Operating Activities | 30 | 15 | 35 | -11 | 15 | 24 |
| Financing Activities | 15 | 12 | -3 | 11 | 17 | -7 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 68.26 % | 67.74 % | 67.74 % | 67.69 % | 68.96 % | 69.85 % | 69.86 % | 70.32 % | 70.32 % | 70.32 % | 70.32 % | 70.68 % | 71.19 % | 71.41 % | 71.41 % | 71.41 % | 71.41 % | 71.41 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.02 % | 0.00 % | 0.00 % | 0.03 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 28.99 % | 28.74 % | 30.00 % | 30.14 % | 28.43 % | 27.60 % | 26.85 % | 26.11 % | 25.98 % | 25.97 % | 26.01 % | 25.69 % | 25.64 % | 25.56 % | 25.56 % | 25.51 % | 25.55 % | 25.55 % |
| Others | 2.75 % | 3.51 % | 2.25 % | 2.17 % | 2.61 % | 2.55 % | 3.30 % | 3.57 % | 3.69 % | 3.71 % | 3.67 % | 3.63 % | 3.17 % | 3.02 % | 3.01 % | 3.08 % | 3.04 % | 3.01 % |
| No of Share Holders | 9,563 | 10,329 | 9,580 | 8,843 | 8,841 | 8,939 | 8,799 | 8,593 | 8,349 | 8,475 | 8,443 | 8,233 | 8,116 | 7,861 | 7,849 | 7,626 | 7,479 | 7,412 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1.5 | 0.00 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.84 | 0.00 | 0.21 | 0.29 | 0.22 | 0.14 | 0.13 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2025 |  Annual General Meeting | NA | 30 Sept 2025 | 1,100.10 | 1,145.00 |
| 22 Jun 2016 |  Change Of Name | NA | 22 Jun 2016 | 0.00 | 0.00 |
| 21 Sept 2021 |  Dividend | ₹ 1.50 /share | 20 Sept 2021 | 625.80 | 728.70 |
| 24 Sept 2022 | Dividend | ₹ 1.50 /share | 22 Sept 2022 | 626.05 | 681.35 |
| 23 Sept 2023 | Dividend | ₹ 1.50 /share | 22 Sept 2023 | 557.75 | 511.80 |
| 23 Sept 2024 | Dividend | ₹ 1.50 /share | 23 Sept 2024 | 658.00 | 1,517.00 |
| 30 Sept 2024 | Annual General Meeting | NA | 30 Sept 2024 | 938.45 | 1,455.00 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 1,354.65 | 1,218.40 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,270.00 | 1,188.00 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 1,285.00 | 1,347.55 |
| 11 Aug 2025 | Quarterly Result Announcement | NA | 11 Aug 2025 | 1,216.95 | 1,134.80 |
| 24 Sept 2025 | Dividend | ₹ 1.50 /share | 24 Sept 2025 | 1,347.55 | 1,200.00 |
Announcements
ANVISA Inspection1 day ago
1 day agoClosure of Trading Window8 days ago
8 days agoReport (Special Window)Sep 15, 2025
Sep 15, 2025Annual Report (Weblink)Sep 09, 2025
Sep 09, 2025Newspaper Advertisement (AGM Notice)Sep 06, 2025
Sep 06, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025AGM Notice (Sept 30 2025)Sep 06, 2025
Sep 06, 2025Record Date (Dividend)Aug 28, 2025
Aug 28, 2025Events Calendar (AGM)Aug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Change of Company NameAug 21, 2025
Aug 21, 2025Newspaper Publication (Financial Results)Aug 12, 2025
Aug 12, 2025Financial Results (Q1/F26)Aug 11, 2025
Aug 11, 2025Board Meeting Outcome for Meeting Held On Aug 11 2025Aug 11, 2025
Aug 11, 2025Board Meeting Intimation for 94Th Board Meeting (11.08.2025)Aug 06, 2025
Aug 06, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 01, 2025
Aug 01, 2025Newspaper Advertisement (Special Window)Jul 23, 2025
Jul 23, 2025Establishment Inspection ReportJul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Communication To ShareholdersJul 01, 2025
Jul 01, 2025Newspaper Publication (Postal Ballot)Jul 01, 2025
Jul 01, 2025Postal Ballot Notice (01.07.2025 - 30.07.2025)Jun 30, 2025
Jun 30, 2025Events Calendar (Postal Ballot)Jun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Newspaper Publication (Financial Results)May 31, 2025
May 31, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Financial Results (Q4/F25)May 29, 2025
May 29, 2025Reappointment Of AuditorsMay 29, 2025
May 29, 2025Reappointment Of Executive DirectorMay 29, 2025
May 29, 2025Board Meeting Outcome for 93Rd Board Meeting.May 29, 2025
May 29, 2025Board Meeting Intimation for 93Rd Board Meeting (29.05.2025)May 22, 2025
May 22, 2025USFDA InspectionMay 09, 2025
May 09, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 02, 2025
May 02, 2025Credit Ratings (Withdrawal)Apr 10, 2025
Apr 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Annual Confirmation (Reclassification)Apr 05, 2025
Apr 05, 2025Encumbrance (Annual Disclosure)Apr 05, 2025
Apr 05, 2025Newspaper Publication (Postal Ballot)Mar 31, 2025
Mar 31, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 31, 2025
Mar 31, 2025 Events Calendar (Postal Ballot)Mar 28, 2025
Mar 28, 2025Name Change (Update)Mar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 20, 2025
Mar 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 20, 2025
Mar 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 20, 2025
Mar 20, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 20, 2025
Mar 20, 2025Shareholders Queries (Weblink)Mar 06, 2025
Mar 06, 2025Clarification (Credit Ratings)Mar 04, 2025
Mar 04, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Credit RatingFeb 22, 2025
Feb 22, 2025Newspaper Publication (Financial Results)Feb 14, 2025
Feb 14, 2025Technical Indicators
RSI(14)
Neutral 45.66
ATR(14)
Volatile 52.35
STOCH(9,6)
Neutral 46.50
STOCH RSI(14)
Neutral 21.79
MACD(12,26)
Bearish -1.74
ADX(14)
Strong Trend 26.49
UO(9)
Bearish 43.45
ROC(12)
Downtrend And Accelerating -1.06
WillR(14)
Oversold -88.07
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
